药食同源杂志2025，Vol.1Issue(4)：60-70,11.
基于文献计量学的乳香研究现状及热点分析
Current research status and hotspot analysis of Ruxiang(Olibanum)based on bibliometrics
摘要
Abstract
Objective To analyze the research hotspots and frontiers in the field of Ruxiang(Olibanum)by reviewing literature on Ruxiang(Olibanum)published in recent years.Methods Literature data were retrieved from the China National Knowledge Infrastructure(CNKI)and Web of Science databases.CiteSpace was used to analyze annual number of publications,institutions,keywords,and authors,and to generate visualized maps.Results A total of 689 publications in Chinese and 406 publications in English were identified.The overall number of publications showed an upward trend;the institution with the highest number of Chinese publications was the National Institutes for Food and Drug Control(24 articles),and for English publications was the University of Nizwa(31 articles).The most prolific authors were LIU Zhenli(17 articles)for Chinese publications and Al-harrasi,Ahmed(31 articles)for English publications.The journals with the highest number of publications were Chinese Traditional and Herbal Drugs(25 articles)in Chinese,and Molecules(11 articles)in English.Keyword analysis in both Chinese and English literature indicated that major research on Ruxiang(Olibanum)has focused on pharmacological activities and chemical components.Conclusion Research on Ruxiang(Olibanum)is currently in a stage of steady development.Future research hotspots in this field are predicted to focus on boswellic acids,volatile oils,inflammation,breast cancer,and oral cancer.Enhanced interdisciplinary communication and collaboration between domestic and international research teams are recommended to enable more in-depth investigations.关键词
乳香/可视化分析/乳香酸/研究热点/抗炎Key words
Ruxiang(Olibanum)/visualization analysis/boswellic acids/research hotspots/anti-inflammation分类
医药卫生引用本文复制引用
贾瑶,肖明珠,邹会品,阳睦贤,周逸群,石继连..基于文献计量学的乳香研究现状及热点分析[J].药食同源杂志,2025,1(4):60-70,11.基金项目
中药炮制技术传承基地开放基金(2022ZYZ09) （2022ZYZ09）
研究生创新课题项目(2024CX174). （2024CX174）
